Make the right call

in COVID-19 care

Protecting the people in your care, on your staff and their families has never been more essential – especially when they may be at higher risk for life-threatening complications.

The BIOCARD® Pro COVID-19 Rapid Antigen Test detects multiple COVID-19 variants, even at low viral loads, giving you an even wider window in which to identify positive cases so you can be sure you have the accurate results you need to make the right decisions for those who depend on you.

Available Purchase Options

25 Count
When you are responsible for the healthcare of others, you need a COVID-19 test that is highly accurate and makes testing many easy and cost effective. Millions trust New Day’s BIOCARD Covid-19 test as it detects Omicron and Delta variants, even with low viral loads. Available at most major healthcare distributors and on-line at Amazon.1
2 Count
New Day’s BIOCARD COVID-19 accurately detects Omicron and Delta variants. Get fast, accurate results in just 10 minutes so you can protect yourself and your loved ones. Available in retail stores and on-line at Amazon.1
Real Benefits
Group 69

Breadth of Detection

Compared to PCR testing, our test had a PPA of 92% of Ct values up to 34. By detecting positive cases even early and late in disease progression at very low viral loads, the test offers a wider window in which to identify COVID-19.
Group 72

Highly Accurate

Our test showed excellent sensitivity and specificity in detecting positive cases of COVID-19, including the Omicron and Delta variants, with 87.2% PPA and 100% NPA in symptomatic patients.

Unique Test Design

Other tests simply dip or swirl the nasal swab in the buffer solution. Ours ensures high accuracy by leaving the swab in the solution – allowing it to process for two minutes before dripping the sample onto the proprietary test card.

Ready to Experience the Difference Yourself?

Join the list of healthcare providers working with New Day Diagnostics to provide accurate rapid testing to their patients and staff. Talk to us today to learn more, receive a sample and explore pricing information.

Bring Confidence to Any Care Setting

Urgent Care

Speed is essential in any urgent care environment, and you need to know right away whether a patient is experiencing symptoms of COVID-19 or another illness. Our test delivers highly accurate results in just 10 minutes, so you can offer informed care plans sooner and keep your workflow moving.

Long-Term Care

You want to provide the best possible care to your patients, while reducing the chance of an outbreak among residents, visitors and staff. Our test provides the accurate results and early detection you need to make confident decisions that keep everyone safe and healthy.

Community Health Clinics

Some of your patients may not be able to receive regular care, which makes it essential to diagnose and treat them in a single visit. Our test offers quick, highly accurate results without the need for on-site diagnostic equipment, so you can create a care plan right away.

Other Locations
Schools, businesses, physician offices, travel testing sites and more can all benefit from fast, accurate and easy COVID-19 diagnostics. Talk to us today about meeting your own testing needs.

How To Use the Test

Instructions For Use (IFU): Please carefully read and follow all instructions. It is important that you complete the test steps as accurately as possible to ensure reliable results.

Additional Information & Links

1 CE Approval for sale in Europe.
*PPA = positive percent agreement
**NPA = negative percent agreement

†Ct values = cycle threshold value. The higher the Ct, the more PCR cycles it took to identify the presence of the antigen. This means that a higher Ct indicates lower viral loads.

  • This product has been authorized by the FDA under an Emergency Use Authoization (EUA)
  • This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens.
  • The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb3(b)(1), unless the declaration is terminated or authorization is revoked sooner.